You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Phase 2, double-blind, randomized, parallel-group, placebo-controlled, multicenter study, comparing budesonide pMDI 160 μg bid with placebo: a 6-week efficacy and safety study in children aged 6 to <12 years with asthma
- Disease
- asthma
- Drug Name
- Symbicort
- Generic Name
- budesonide
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- II
- Start Date
- Jul 26, 2010
- Study Name
- D589GC00001
- Study Id
- D589GC00001
- ClinicalTrials.gov ID
- NCT01136382
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
